Stocks Comparison
Alignment Healthcare vs Molina Healthcare: revenue, profit, margins and growth compared
Alignment Healthcare brought in $3.9B of revenue in fiscal 2025, Molina Healthcare $45.4B in fiscal 2025. Revenue changed by +46.1% at Alignment Healthcare and +11.7% at Molina Healthcare on the year before, so Alignment Healthcare grew faster. Alignment Healthcare kept -0.0% of its revenue as net profit, Molina Healthcare 1.0%. Free cash flow was $113.1M at Alignment Healthcare and -$636M at Molina Healthcare.
Side by side, latest fiscal year
| ALHC | MOH | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $3.9B | $45.4B |
| Revenue growth | +46.1% | +11.7% |
| Net income | -$724K | $472M |
| Net margin | -0.0% | 1.0% |
| Free cash flow | $113.1M | -$636M |
| Free cash flow margin | 2.9% | -1.4% |
| Earnings per share (diluted) | $0.00 | $8.92 |
| Cash | $575.8M | $4.2B |
| Debt | $323.2M | $3.8B |
| Price to earnings | n/a | 21.4 |
| Market value | $1.7B | $10B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #73 of 523 · Health care | #17 of 523 · Health care |
Over the years
Questions about Alignment Healthcare and Molina Healthcare
Which is bigger by revenue, Alignment Healthcare or Molina Healthcare?
Molina Healthcare is bigger by revenue: $45.4B in fiscal 2025, against $3.9B for Alignment Healthcare in fiscal 2025.
Which keeps more of its revenue as profit, Alignment Healthcare or Molina Healthcare?
Alignment Healthcare had a net margin of -0.0% in fiscal 2025; Molina Healthcare had 1.0% in fiscal 2025.
Which grew revenue faster, Alignment Healthcare or Molina Healthcare?
In their latest fiscal years revenue changed by +46.1% at Alignment Healthcare and +11.7% at Molina Healthcare.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.